GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 166 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $595,277 | +32.6% | 24,907 | -19.0% | 0.01% | +20.0% |
| Q4 2020 | $449,038 | +2.8% | 30,756 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $436,735 | -3.5% | 30,756 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $452,421 | +316.7% | 30,756 | +16.7% | 0.01% | +150.0% |
| Q1 2020 | $108,562 | -14.3% | 26,350 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $126,744 | -20.6% | 26,350 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $159,681 | -6.6% | 26,350 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $171,012 | -8.5% | 26,350 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $186,822 | +45.9% | 26,350 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $128,061 | -33.9% | 26,350 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $193,673 | +15.3% | 26,350 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $168,000 | +17.5% | 26,350 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $143,000 | – | 26,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 2,730,000 | $11,384,000 | 2.77% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,017,483 | $20,923,000 | 1.28% |
| Ghost Tree Capital, LLC | 500,000 | $2,085,000 | 0.49% |
| Bellevue Group AG | 773,677 | $3,226,000 | 0.34% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 180,000 | $750,000 | 0.20% |
| Penn Capital Management Company, LLC | 543,715 | $2,267,000 | 0.16% |
| HighTower Advisors, LLC | 2,355,942 | $9,826,000 | 0.08% |
| Granite Investment Partners, LLC | 215,760 | $900,000 | 0.06% |
| WRAPMANAGER INC | 39,547 | $165,000 | 0.05% |
| Alyeska Investment Group, L.P. | 1,563,881 | $6,521,000 | 0.05% |